- Fu, Ting;
- Huan, Tao;
- Rahman, Gibraan;
- Zhi, Hui;
- Xu, Zhenjiang;
- Oh, Tae Gyu;
- Guo, Jian;
- Coulter, Sally;
- Tripathi, Anupriya;
- Martino, Cameron;
- McCarville, Justin L;
- Zhu, Qiyun;
- Cayabyab, Fritz;
- Low, Brian;
- He, Mingxiao;
- Xing, Shipei;
- Vargas, Fernando;
- Yu, Ruth T;
- Atkins, Annette;
- Liddle, Christopher;
- Ayres, Janelle;
- Raffatellu, Manuela;
- Dorrestein, Pieter C;
- Downes, Michael;
- Knight, Rob;
- Evans, Ronald M
Colorectal cancer (CRC) is driven by genomic alterations in concert with dietary influences, with the gut microbiome implicated as an effector in disease development and progression. While meta-analyses have provided mechanistic insight into patients with CRC, study heterogeneity has limited causal associations. Using multi-omics studies on genetically controlled cohorts of mice, we identify diet as the major driver of microbial and metabolomic differences, with reductions in α diversity and widespread changes in cecal metabolites seen in high-fat diet (HFD)-fed mice. In addition, non-classic amino acid conjugation of the bile acid cholic acid (AA-CA) increased with HFD. We show that AA-CAs impact intestinal stem cell growth and demonstrate that Ileibacterium valens and Ruminococcus gnavus are able to synthesize these AA-CAs. This multi-omics dataset implicates diet-induced shifts in the microbiome and the metabolome in disease progression and has potential utility in future diagnostic and therapeutic developments.